Retatrutide Withdrawal and Taper Protocol: How to Stop Without Appetite Rebound and Fat Regain

Retatrutide withdrawal is the question every UK bodybuilder asks after the cut is over: what happens when you stop, and how do you prevent the appetite rebound and fat regain that clinical data shows occurs with every GLP-1 class compound? A 2025 systematic review and meta-regression published in eClinicalMedicine modelled the trajectory of weight regain after GLP-1 receptor agonist discontinuation and found that 60% of weight lost during treatment is regained within one year of cessation, with the fastest regain occurring in the first 12 to 16 weeks. Abrupt cessation produces the most dramatic rebound because the appetite-suppressing, metabolic-enhancing and insulin-sensitising effects of the compound disappear simultaneously while the body’s counter-regulatory hunger signals are at their strongest. This guide provides the structured retatrutide withdrawal and taper protocol that bodybuilders need to transition off Retatrutide 2mg without losing the body composition progress they spent months building. Available from Intex Pharma UK, understanding when and how to stop retatrutide is as important as knowing how to start it.

Why Abrupt Retatrutide Withdrawal Causes Appetite Rebound

During retatrutide use, three receptor pathways are tonically suppressing appetite and enhancing metabolic function. GLP-1 receptor activation suppresses ghrelin, enhances satiety signalling and dampens the mesolimbic reward response to food. GIP receptor activation stabilises glucose disposal and supports nutrient partitioning. Glucagon receptor activation promotes hepatic fatty acid oxidation and energy expenditure. When retatrutide is abruptly withdrawn, all three pathways deactivate within days (retatrutide’s half-life is approximately 6 days, so plasma levels drop significantly within 1 to 2 weeks of the last injection).

The body responds to this sudden loss of appetite suppression with a compensatory orexigenic surge. Ghrelin secretion, which was pharmacologically suppressed, rebounds above pre-treatment baseline levels. Leptin sensitivity, which improved during treatment alongside fat loss, has not had time to recalibrate to the leaner body composition. Hypothalamic NPY/AgRP neurons, which were tonically inhibited by GLP-1 receptor activation, reactivate with a burst of hunger signalling that users describe as overwhelming: not ordinary hunger, but an intense, driven appetite for calorie-dense food that feels neurologically compulsive. This is the same mechanism that makes post-diet binge eating so common in natural dieters, but amplified by the sudden removal of pharmacological suppression that the brain had adapted to.

A 2025 meta-analysis in Cureus quantified this rebound: semaglutide users regained an average of 5.15kg after discontinuation, while dual and triple agonist users (with stronger on-treatment effects) showed proportionally greater regain because the compensatory metabolic disruption was more pronounced upon withdrawal of multi-receptor activation. The implication for retatrutide users is clear: because retatrutide activates three receptors, the withdrawal rebound from abrupt cessation is likely to be at least as significant as tirzepatide’s (which showed greater rebound than semaglutide in subgroup analysis). A structured taper is not optional. It is the pharmacological equivalent of reverse dieting after a caloric deficit.

The Structured Retatrutide Withdrawal Taper for Bodybuilders

The taper principle is straightforward: reduce the dose gradually over 4 to 8 weeks so the brain’s appetite-regulatory circuits have time to recalibrate to lower levels of receptor activation before the compound is fully withdrawn. Each dose reduction allows a partial return of appetite signalling, which the user manages through conscious dietary discipline at a level that is manageable (unlike the overwhelming surge of abrupt cessation). By the time the final dose is administered, the appetite increase is incremental rather than catastrophic.

Timing the Taper: When to Start Retatrutide Withdrawal

The timing of the retatrutide taper depends on where you are in your bodybuilding calendar. Each scenario has a different optimal start point.

The Reverse Diet Connection: Why Taper and Reverse Diet Must Run Together

Reverse dieting (gradually increasing calories from a deficit back to maintenance) is standard practice after any bodybuilding cut. On retatrutide, the reverse diet and the taper are the same protocol viewed from two angles: calories go up while the drug dose comes down, in matched increments. Reducing retatrutide by 25% produces a predictable appetite increase that the 100 to 200 calorie increase absorbs. The user feels slightly hungrier, eats slightly more and maintains energy balance at each step.

The mistake is tapering retatrutide without reverse dieting (appetite returns but calories stay at cutting levels, producing unbearable hunger and inevitable binging) or reverse dieting without tapering retatrutide (calories increase but appetite stays suppressed, then the abrupt cessation of retatrutide produces a massive appetite surge when calories are already at maintenance, pushing the user into surplus). Both must proceed together. For the complete reverse dieting protocol with retatrutide, see the guide on retatrutide and reverse dieting to prevent fat overshoot.

Anabolic Support During the Taper: Protecting Lean Mass After the Cut

During the taper, the user is transitioning from a cutting pharmacological environment to a maintenance or off-season one. If the steroid cycle is ending simultaneously, the user faces compound withdrawals: retatrutide appetite suppression diminishing while anabolic support also disappears. Stagger these transitions rather than removing everything at once.

If transitioning to PCT, maintain retatrutide at full dose through the entire PCT phase (see the PCT protocol with HCG and Clomid). Begin the retatrutide taper only after post-PCT bloodwork confirms endogenous testosterone has recovered. Testosterone Enanthate 300mg at TRT dose throughout the taper period provides the anabolic baseline that prevents lean mass loss during the caloric transition. Users who ran 19-nor compounds should continue Cabergoline 0.25mg per the cabergoline during PCT guide until prolactin normalises on bloodwork. Confirm recovery with the pre-cycle bloodwork panel and the testosterone bloodwork interpretation guide.

What the First 4 Weeks After Cessation Feel Like

Even with a proper taper, the first 2 to 4 weeks after the final retatrutide injection involve an adjustment period. Appetite will increase beyond what it was during the taper because the residual compound is clearing from your system (half-life approximately 6 days means it takes roughly 4 to 5 half-lives, or 24 to 30 days, for near-complete clearance). During this window, the following strategies protect body composition.

Pre-plan every meal. Do not leave food decisions to the moment of hunger. Prepare meals in advance and eat them on schedule regardless of appetite level. The hunger will feel urgent and convincing. Having food ready and portioned prevents impulse-driven overeating.

Prioritise high-volume, low-calorie-density foods. Vegetables, lean protein, high-fibre carbohydrates and water-rich foods produce mechanical satiety (stomach distension) that partially replaces the pharmacological satiety that retatrutide provided. Fill the plate with volume.

Remove trigger foods from your environment. The post-withdrawal appetite surge specifically targets calorie-dense, palatable foods (the same mesolimbic reward response that retatrutide was dampening). If those foods are not in the house, the friction between craving and consumption provides a window for the urge to pass.

Maintain training volume. Resistance training maintains the metabolic rate that lean mass provides and generates the mechanical stimulus that signals the body to preserve muscle. Do not reduce training during the taper or post-cessation window. If anything, increase training frequency slightly to maintain the caloric expenditure that retatrutide’s metabolic effects were contributing.

Retatrutide Withdrawal and Taper: Frequently Asked Questions